Medicine and Dentistry
Ocular Surface Disease
100%
Atopic Dermatitis
100%
Dupilumab
100%
Biological Therapy
100%
Disease of Ocular Surface
30%
Targeted Therapy
23%
Goblet Cell
23%
Eczema
15%
Intraocular Drug Administration
15%
Cell Function
7%
Clinician
7%
Patient Referral
7%
Anti-Inflammatory Drug
7%
Prospective Study
7%
Biological Marker
7%
Disease Severity
7%
Eye
7%
Drug Dose Reduction
7%
Dermatitis
7%
Mucin 5AC
7%
Ocular Pathology
7%
Nursing and Health Professions
Atopic Dermatitis
100%
Biological Therapy
100%
Ocular Surface Disease
100%
Dupilumab
81%
Eczema
12%
Intraocular Drug Administration
12%
Patient Referral
6%
Disease Severity
6%
Ophthalmologist
6%
Blood Level
6%
Biological Marker
6%
Dermatitis
6%
Drug Dose Reduction
6%
Cell Count
6%
Mucin 5AC
6%
Pharmacology, Toxicology and Pharmaceutical Science
Atopic Dermatitis
100%
Ocular Surface Disease
100%
Dupilumab
81%
Eczema
12%
Agents Acting on the Eye
12%
Biological Marker
6%
Anti-Inflammatory Drug
6%
Dermatitis
6%
Prospective Study
6%
Disease Severity
6%
Mucin 5AC
6%
Immunology and Microbiology
Atopic Dermatitis
100%
Dupilumab
100%
Goblet Cell
23%
Eczema
15%
Liquid
15%
Eyelid
15%
Blood Level
7%
Mucin
7%
Cell Function
7%
Dermatitis
7%
Drug Dose Reduction
7%